Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-06-04
2000-04-04
Reamer, James H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31425
Patent
active
060462221
ABSTRACT:
Novel methods of using thiazolidinone derivatives and related antihyperglycemic agents to treat populations at risk for developing noninsulin-dependent diabetes mellitus (NIDDM) and complications arising therefrom are disclosed. In one embodiment, the compounds of the invention are used to treat polycystic ovary syndrome in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus. In another embodiment, the compounds of the invention are used to treat gestational diabetes in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus.
REFERENCES:
patent: 4287200 (1981-09-01), Kawamatsu et al.
patent: 4572912 (1986-02-01), Yoshioka et al.
patent: 4687777 (1987-08-01), Meguro et al.
patent: 4873255 (1989-10-01), Yoshioka et al.
patent: 4897405 (1990-01-01), Alessi et al.
patent: 5061717 (1991-10-01), Clark et al.
patent: 5120754 (1992-06-01), Clark et al.
patent: 5132317 (1992-07-01), Cantello et al.
patent: 5223522 (1993-06-01), Clark et al.
patent: 5457109 (1995-10-01), Antonucci et al.
patent: 5602133 (1997-02-01), Antonucci et al.
PCT International Search Report, PCT/US98/10472, Mailed Sep. 25, 1998.
Leroith, D., et al.: "Diabetes Mellitus" 1996, Lippincott-Raven, Philadelphia, XP002077274, p. 661-668, and Whitcomb, R.W., et al., "New Therapies for Non-insulin-Dependent Diabetes Mellitus: Thiazolidinediones" Chapter 74, 1996.
Ooshima, Y. and Ihara, T., "Embryopathy in Genetically Diabetic Mice, Yellow KK, and its Prevention by Maternal Therapy" Cong. Anom., 1986, vol. 26, No. 3, pp. 169-177.
Bloomgarden, Z.T., "American Diabetes Association Annual Meeting 1996: The Etiology of Type II Diabetes, Obesity, and the Treatment of Type II Diabetes" Diabetes Care, Nov. 1996, vol. 19, No. 11, pp. 1311-1315.
The New England Journal of Medicine, vol. 319, No. 23, 1988, pp. 1500-1506, Saad et al.
Diabetes Care, vol. 15, No. 8, 1992, pp 1075-1078, Hofmann et al.
J. Med. Chem., vol. 35, No. 14, 1992, pp 2617-2626, Sohda et al.
Chemical Abstracts, vol. 119, No. 1, 1993, abstract No. 97.
Annals of the New York Academy of Sciences, vol. 687, 1993, pp 60-64, Dunaif.
Annales d'Endocrinologie (Paris), vol. 53, No. 1, 1992, pp 1-7, Dewailly et al.
Diabetologia, vol. 34, 1991, p. A198, Robinson et al.
PCT International Search Report, PCT/US 94/10187.
Drugs, 44 (Suppl. 3):29-38, 1992, Lefebvre et al.
The Lancet, 1:870-872, 1988, Polson et al.
Obstetrics & Gynecology, 66:545-552, 1985, Dunaif et al.
Metabolism, 38:1089-1093, 1989, Kraegen et al.
Diabetes, 37:1549-1558, 1988, Fujiwara et al.
Diabetes Res. and Clin. Practice, 11:147-153, 1991, Kuzaza et al.
Diabetes Care, 15:193-203, 1992, Suter et al.
Diabetes Care, 14:1083-1086, 1991, Iwamoto et al.
Antonucci Tammy
Lockwood Dean
Norris Rebecca
Ashbrook Charles W.
Reamer James H.
Warner-Lambert & Company
LandOfFree
Use of thiazolidinedione derivatives in the treatment of polycys does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of thiazolidinedione derivatives in the treatment of polycys, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of thiazolidinedione derivatives in the treatment of polycys will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-365695